|
US5739166A
(en)
*
|
1994-11-29 |
1998-04-14 |
G.D. Searle & Co. |
Substituted terphenyl compounds for the treatment of inflammation
|
|
US5686470A
(en)
*
|
1995-02-10 |
1997-11-11 |
Weier; Richard M. |
2, 3-substituted pyridines for the treatment of inflammation
|
|
US5596008A
(en)
*
|
1995-02-10 |
1997-01-21 |
G. D. Searle & Co. |
3,4-Diaryl substituted pyridines for the treatment of inflammation
|
|
US5861419A
(en)
|
1996-07-18 |
1999-01-19 |
Merck Frosst Canad, Inc. |
Substituted pyridines as selective cyclooxygenase-2 inhibitors
|
|
IL127441A
(en)
*
|
1996-07-18 |
2003-02-12 |
Merck Frosst Canada Inc |
Substituted pyridines, pharmaceutical compositions comprising them and their use in the preparation of anti-inflammatory medicaments or as selective cyclooxygenase-2 inhibitors
|
|
ES2212119T3
(es)
|
1996-07-31 |
2004-07-16 |
SHIONOGI & CO., LTD. |
Nuevos compuestos de p-terfenilo.
|
|
US6525053B1
(en)
|
1997-08-22 |
2003-02-25 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
|
US6307047B1
(en)
|
1997-08-22 |
2001-10-23 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
|
US6046217A
(en)
*
|
1997-09-12 |
2000-04-04 |
Merck Frosst Canada & Co. |
2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
|
|
US6004950A
(en)
*
|
1997-09-12 |
1999-12-21 |
Merck Frosst Canada, Inc. |
2-aminopyridines as inhibitors of cyclooxygenase-2
|
|
AR015938A1
(es)
|
1997-09-25 |
2001-05-30 |
Merck Sharp & Dohme |
Procedimiento para preparar diaril piridinas utiles como inhibidores cox-2 y compuesto intermediario
|
|
US6040450A
(en)
|
1997-09-25 |
2000-03-21 |
Merck & Co., Inc. |
Process for making diaryl pyridines useful as cox-2-inhibitors
|
|
US7041694B1
(en)
|
1997-12-17 |
2006-05-09 |
Cornell Research Foundation, Inc. |
Cyclooxygenase-2 inhibition
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
CA2314896C
(en)
*
|
1997-12-22 |
2005-09-13 |
Euro-Celtique, S.A. |
A method of preventing abuse of opioid dosage forms
|
|
JP2001526228A
(ja)
|
1997-12-22 |
2001-12-18 |
ユーロ−セルティーク，エス．エイ． |
オピオイド作動薬／拮抗薬の併用
|
|
US7253165B2
(en)
*
|
1999-09-14 |
2007-08-07 |
Aventis Pharmaceuticals Inc. |
Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
|
|
US7125903B1
(en)
|
1999-09-14 |
2006-10-24 |
Aventis Pharmaceuticals Inc. |
Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
|
|
US7091199B1
(en)
|
1999-09-14 |
2006-08-15 |
Aventis Pharmaceuticals Inc. |
Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
|
|
DE10001166A1
(de)
|
2000-01-13 |
2001-07-19 |
Merckle Gmbh |
Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung
|
|
HU229705B1
(en)
|
2000-02-08 |
2014-05-28 |
Euro Celtique Sa |
Tamper-resistant oral opioid agonist formulations
|
|
EP1935421A1
(en)
|
2000-02-08 |
2008-06-25 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
|
PH12001001175B1
(en)
*
|
2000-05-26 |
2006-08-10 |
Merck Sharp & Dohme |
5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis
|
|
US6664256B1
(en)
|
2000-07-10 |
2003-12-16 |
Kowa Co., Ltd. |
Phenylpyridazine compounds and medicines containing the same
|
|
DE60122939T2
(de)
*
|
2000-12-21 |
2007-01-11 |
Nitromed, Inc., Bedford |
Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren
|
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
|
CN1525851A
(zh)
|
2001-05-11 |
2004-09-01 |
������ҩ������˾ |
抗滥用阿片样物质控释剂型
|
|
SI1416842T1
(sl)
*
|
2001-07-18 |
2009-06-30 |
Euro Celtique Sa |
Farmacevtske kombinacije oksikodona in naloksona
|
|
AU2002324624A1
(en)
|
2001-08-06 |
2003-02-24 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
|
ATE431738T1
(de)
|
2001-08-06 |
2009-06-15 |
Euro Celtique Sa |
Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
US20030044458A1
(en)
*
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
KR100809489B1
(ko)
*
|
2001-10-10 |
2008-03-03 |
씨제이제일제당 (주) |
사이클로옥시게나제-2의 저해제로서 선택성이 뛰어난4'-메탄설포닐-비페닐 유도체
|
|
GB0128996D0
(en)
|
2001-12-04 |
2002-01-23 |
Novartis Ag |
Organic compounds
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
US6797825B2
(en)
|
2001-12-13 |
2004-09-28 |
Abbott Laboratories |
Protein kinase inhibitors
|
|
EP1492784A4
(en)
*
|
2002-03-28 |
2006-03-29 |
Merck & Co Inc |
SUBSTITUTED 2,3-DIPHENYLPYRIDINES
|
|
EP1492505B1
(en)
|
2002-04-05 |
2015-06-03 |
Euro-Celtique S.A. |
Pharmaceutical preparation containing oxycodone and naloxone
|
|
US7244753B2
(en)
*
|
2002-07-29 |
2007-07-17 |
Nitromed, Inc. |
Cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
US7815934B2
(en)
|
2002-09-20 |
2010-10-19 |
Alpharma Pharmaceuticals, Llc |
Sequestering subunit and related compositions and methods
|
|
WO2005000194A2
(en)
|
2002-10-08 |
2005-01-06 |
Rinat Neuroscience Corp. |
Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same
|
|
ZA200502612B
(en)
*
|
2002-10-08 |
2007-07-25 |
Rinat Neuroscience Corp |
Methods for treating post-surgical pain by administering a nerve crowth factor antagonist and compositions containing the same
|
|
GB0225548D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Compounds
|
|
US20040138301A1
(en)
*
|
2002-11-08 |
2004-07-15 |
Hansen Birgit Sehested |
Chemical uncouplers for the treatment of obesity
|
|
US20040102421A1
(en)
*
|
2002-11-21 |
2004-05-27 |
Children's Hospital Research Center At Oakland |
Tocopherol and tocotrienol anti-inflammatory medicaments
|
|
US7569364B2
(en)
*
|
2002-12-24 |
2009-08-04 |
Pfizer Inc. |
Anti-NGF antibodies and methods using same
|
|
US9498530B2
(en)
|
2002-12-24 |
2016-11-22 |
Rinat Neuroscience Corp. |
Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
|
|
DK2270048T3
(en)
|
2002-12-24 |
2016-01-18 |
Rinat Neuroscience Corp |
Anti-NGF antibodies and methods for their use
|
|
BRPI0407375A
(pt)
*
|
2003-02-19 |
2006-02-07 |
Rinat Neuroscience Corp |
Métodos para tratar dor por meio da administração de um antagonista do fator de crescimento neural e u nsaid e composições contendo os mesmos
|
|
RU2366655C2
(ru)
|
2003-03-14 |
2009-09-10 |
Оно Фармасьютикал Ко., Лтд. |
Азотсодержащие гетероциклические производные и лекарственные средства, содержащие их в качестве активного ингредиента
|
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
EP1663229B1
(en)
|
2003-09-25 |
2010-04-14 |
Euro-Celtique S.A. |
Pharmaceutical combinations of hydrocodone and naltrexone
|
|
WO2005044227A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Glenmark Pharmaceuticals Limited |
Topical pharmaceutical compositions
|
|
US20050100594A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Nilendu Sen |
Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor
|
|
EP3372614B1
(en)
|
2004-04-07 |
2022-06-08 |
Rinat Neuroscience Corp. |
Methods for treating bone cancer pain by administering a nerve growth factor antagonist
|
|
EP1604666A1
(en)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
|
CA2916869A1
(en)
|
2004-06-12 |
2005-12-29 |
Jane C. Hirsh |
Abuse-deterrent drug formulations
|
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7271383B2
(en)
*
|
2004-08-11 |
2007-09-18 |
Lexmark International, Inc. |
Scanning system with feedback for a MEMS oscillating scanner
|
|
US8143404B2
(en)
|
2004-09-13 |
2012-03-27 |
Ono Pharmaceutical Co., Ltd |
Nitrogenous heterocylic derivative and medicine containing the same as an active ingredient
|
|
GB0611907D0
(en)
|
2006-06-15 |
2006-07-26 |
Glaxo Group Ltd |
Compounds
|
|
EP1702558A1
(en)
*
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
|
SI1907374T1
(sl)
*
|
2005-07-26 |
2012-11-30 |
Glaxo Group Ltd |
Derivati benzilpiperazina uporabni za zdravljenje gastrointestinalnih motenj
|
|
CA2644368A1
(en)
|
2006-03-10 |
2007-09-20 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
|
|
SI2719378T1
(sl)
|
2006-06-19 |
2016-11-30 |
Alpharma Pharmaceuticals Llc |
Farmacevtski sestavki
|
|
MX2009000110A
(es)
*
|
2006-06-28 |
2009-01-23 |
Glaxo Group Ltd |
Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor grp38.
|
|
MX2009013332A
(es)
*
|
2007-06-08 |
2010-01-25 |
Mannkind Corp |
Inhibidores de ire-1 alfa.
|
|
US8623418B2
(en)
*
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
|
EP2224808A4
(en)
*
|
2007-12-17 |
2013-11-27 |
Alpharma Pharmaceuticals Llc |
PHARMACEUTICAL COMPOSITION
|
|
RU2478388C2
(ru)
*
|
2008-07-07 |
2013-04-10 |
Еуро-Селтик С.А. |
Фармацевтическая композиция, содержащая опиоидный антагонист, для лечения задержки мочи
|
|
US20100160351A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
|
|
WO2010071865A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
|
|
PL2479166T3
(pl)
|
2009-02-27 |
2014-11-28 |
Cadila Healthcare Ltd |
Sposób otrzymywania etorykoksybu
|
|
MY152279A
(en)
|
2009-03-10 |
2014-09-15 |
Euro Celtique Sa |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
|
WO2011032175A1
(en)
|
2009-09-14 |
2011-03-17 |
Nuon Therapeutics, Inc. |
Combination formulations of tranilast and allopurinol and methods related thereto
|
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
CA2804593C
(en)
|
2010-07-09 |
2015-11-24 |
Pfizer Limited |
Biphenyloxybenzensulphonamide derivatives useful as sodium channel inhibitors
|
|
WO2012024650A2
(en)
|
2010-08-19 |
2012-02-23 |
Abbott Laboratories |
Anti-ngf antibodies and their use
|
|
ME02874B
(me)
|
2010-12-22 |
2018-04-20 |
Purdue Pharma Lp |
Obloženi dozni oblici sa kontrolisanim oslobađanjem otporni na zloupotrebu
|
|
PH12013501345A1
(en)
|
2010-12-23 |
2022-10-24 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
|
JP5889030B2
(ja)
*
|
2011-02-14 |
2016-03-22 |
旭化成イーマテリアルズ株式会社 |
多環式芳香族化合物の製造方法
|
|
PE20141787A1
(es)
|
2011-05-20 |
2014-12-07 |
Alderbio Holdings Llc |
Composiciones anti-cgrp y uso de las mismas
|
|
EP2773618A1
(en)
|
2011-11-03 |
2014-09-10 |
Cadila Healthcare Limited |
An improved process for the preparation of etoricoxib and polymorphs thereof
|
|
CA2875783C
(en)
|
2012-06-06 |
2018-12-11 |
Zoetis Llc |
Caninized anti-ngf antibodies and methods thereof
|
|
ES2630051T3
(es)
|
2012-08-27 |
2017-08-17 |
Cadila Healthcare Limited |
Composición farmacéutica de etoricoxib
|
|
MX2015010041A
(es)
|
2013-02-05 |
2015-10-30 |
Purdue Pharma Lp |
Formulacion farmaceuticas resistentes a la alteracion.
|
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
US10071089B2
(en)
|
2013-07-23 |
2018-09-11 |
Euro-Celtique S.A. |
Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
|
KR102444717B1
(ko)
|
2016-04-15 |
2022-09-16 |
하. 룬드벡 아크티에셀스카브 |
인간화 항-pacap 항체 및 그의 용도
|
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
|
RU2764243C2
(ru)
|
2017-09-22 |
2022-01-14 |
ДЖУБИЛАНТ ЭПИПЭД ЭлЭлСи |
Гетероциклические соединения в качестве ингибиторов PAD
|
|
AU2018352142B2
(en)
|
2017-10-18 |
2022-08-25 |
Jubilant Epipad LLC |
Imidazo-pyridine compounds as PAD inhibitors
|
|
US11629135B2
(en)
|
2017-11-06 |
2023-04-18 |
Jubilant Prodell Llc |
Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
|
|
PT3704120T
(pt)
|
2017-11-24 |
2024-07-03 |
Jubilant Episcribe Llc |
Compostos heterocíclicos como inibidores de prmt5
|
|
BR112020017701A2
(pt)
|
2018-03-12 |
2020-12-29 |
Zoetis Services Llc |
Anticorpos anti-ngf e métodos dos mesmos
|
|
MX2020009517A
(es)
|
2018-03-13 |
2021-01-20 |
Jubilant Prodel LLC |
Compuestos biciclicos como inhibidores de la interaccion/activacio n de pdl/pd-l1.
|
|
IL310885A
(en)
|
2021-08-27 |
2024-04-01 |
H Lundbeck As |
Treatment of cluster headache using anti-CGRP antibodies
|
|
WO2024067463A1
(zh)
*
|
2022-09-27 |
2024-04-04 |
苏州阿尔脉生物科技有限公司 |
苯并[7]环烯类衍生物、包含其的药物组合物及其医药用途
|
|
US20260001942A1
(en)
|
2024-06-21 |
2026-01-01 |
H. Lundbeck A/S |
Treatment of headache disorders and/or psychiatric symptoms using anti-cgrp antibodies, and compositions and methods related thereto
|